HRMY

Harmony Biosciences Holdings
HRMY

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.66B
EV
$1.37B
Shares Outstanding
57.42M
Beta
0.80

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$51.78
P/E 2025E
9.20x
P/Revenue 2025E
1.97x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Harmony Biosciences Holdings, Inc.

gainify
HRMY

Harmony Biosciences Holdings, Inc.

HRMY

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a nov...

Sector

Healthcare

Industry

Biotechnology

CEO

Dayno, Jeffrey

Employees

268

IPO Date

2020-08-19

Headquarters

630 West Germantown Pike, Suite 215, Plymouth Meeting, Pennsylvania, 19462, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved